


| Key | % Net Assets |
|---|---|
| 3.7% | |
| 3.6% | |
| 3.4% | |
| 2.5% | |
| 86.8% |
| Name | % Net Assets |
|---|---|
| Novartis | 3.7% |
| Royal Dutch Petroleum | 3.6% |
| Sanofi-Aventis | 3.4% |
| UBS | 2.5% |
| Total | 2.3% |
| Koninklijke KPN | 2.1% |
| E.ON AG | 2.1% |
| Vivendi Universal | 2.0% |
| ING Group | 1.9% |
| Philips Electronics | 1.7% |
No asset data available.
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 03/07/2000 |
|---|---|
| Fund Manager | Morgan Stanley Investment Mgt Ltd |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | 100000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.40% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.07 |
You are here: research